Two-stage designs with small sample sizes

When applying group-sequential designs in clinical trials with normally distributed outcomes, approximate critical values are often applied. Here, normally distributed test statistics are assumed which, however, are in fact t-distributed. For small sample sizes, the approximation may lead to a serious inflation of the type I error rate. Recently, a method for computing the exact critical boundaries assuring type I error rate control was proposed and the critical boundaries for Pocock- and O'Brien-Fleming-like group-sequential designs were provided. For designs with one interim analysis, we present six alternative designs, which also control the type I error rate and in addition allow flexible design modifications. We compare the characteristics of these 6 two-stage designs. It is shown that considerable sample size savings can be achieved by including futility stopping and by optimizing the designs. Therefore, for clinical trials with small sample sizes as, for example, in the area of rare diseases, optimal two-stage designs with futility stopping may be a valuable alternative to classical group-sequential designs.

Holistic Design of Experiments Using an Integrated Process Model

Statistical experimental designs such as factorial, optimal, or definitive screening designs represent the state of the art in biopharmaceutical process characterization. However, such methods alone do not leverage the fact that processes operate as a mutual interplay of multiple steps. Instead, they aim to investigate only one process step at a time. Here, we want to develop a new experimental design method that seeks to gain information about final product quality, placing the right type of run at the right unit operation. This is done by minimizing the simulated out-of-specification rate of an integrated process model comprised of a chain of regression models that map process parameters to critical quality attributes for each unit operation. Unit operation models are connected by passing their response to the next unit operation model as a load parameter, as is done in real-world manufacturing processes. The proposed holistic DoE (hDoE) method is benchmarked against standard process characterization approaches in a set of in silico simulation studies where data are generated by different ground truth processes to illustrate the validity over a range of scenarios. Results show that the hDoE approach leads to a >50% decrease in experiments, even for simple cases, and, at the same time, achieves the main goal of process development, validation, and manufacturing to consistently deliver product quality.

An Effective Method to Model and Simulate the Behavior of Inductive Angle Encoders

Many angle or position sensors rank among the inductive encoders, although their sensing principle is different. The sensor design investigated in this paper is based on coupled coils, whereas the information about the position angle is modulated on the induced voltage, measured at the receiving coils. Unfortunately, no closed solution for most of the physical quantities exists, since this principle is based on eddy currents, which are rather complex to calculate for the given geometry. Consequently, the common way is to calculate the sensor quantities by a 3D finite-element (FE) simulation. However, this leads in most cases to a high time and computational effort. To overcome the limitations with respect to computational resources, a novel method is presented to reduce simulation effort and calculate regression models, which can even replace simulations. In the following investigations, D-optimal designs are used-a subdomain in the field of statistical design of experiments-and combined with a numerical implementation of Faraday's law, in order to calculate the induced voltages afterwards from simulated magnetic field data. With this method, the sensor signals can be calculated for multiple angle positions from one simulated position by shifting the integration boundaries. Hence, simulation time is significantly reduced for a full period. The regression models obtained by this method, can predict the Tx-coil inductance, induced Rx-voltage amplitude and angular error in dependency of geometric design parameters.

Optimization of sampling designs for pedigrees and association studies

In many studies, related individuals are phenotyped in order to infer how their genotype contributes to their phenotype, through the estimation of parameters such as breeding values or locus effects. When it is not possible to phenotype all the individuals, it is important to properly sample the population to improve the precision of the statistical analysis. This article studies how to optimize such sampling designs for pedigrees and association studies. Two sampling methods are developed, stratified sampling and D optimality. It is found that it is important to take account of mutation when sampling pedigrees with many generations: as the size of mutation effects increases, optimized designs sample more individuals in late generations. Optimized designs for association studies tend to improve the joint estimation of breeding values and locus effects, all the more as sample size is low and the genetic architecture of the trait is simple. When the trait is determined by few loci, they are reminiscent of classical experimental designs for regression models and tend to select homozygous individuals. When the trait is determined by many loci, locus effects may be difficult to estimate, even if an optimized design is used.

Two-stage optimal designs based on exact variance for a single-arm trial with survival endpoints

Sample size calculation based on normal approximations is often associated with the loss of statistical power for a single-arm trial with a time-to-event endpoint. Recently, Wu (2015) derived the exact variance for the one-sample log-rank test under the alternative and showed that a single-arm one-stage study based on exact variance often has power above the nominal level while the type I error rate is controlled. We extend this approach to a single-arm two-stage design by using exact variances of the one-sample log-rank test for the first stage and the two stages combined. The empirical power of the proposed two-stage optimal designs is often not guaranteed under a two-stage design setting, which could be due to the asymptotic bi-variate normal distribution used to estimate the joint distribution of the test statistics. We adjust the nominal power level in the design search to guarantee the simulated power of the identified optimal design being above the nominal level. The sample size and the study time savings of the proposed two-stage designs are substantial as compared to the one-stage design.

Design and analysis of bridging studies with prior probabilities on the null and alternative hypotheses

The pharmaceutical industry and regulatory agencies are increasingly interested in conducting bridging studies in order to bring an approved drug product from the original region (eg, United States or European Union) to a new region (eg, Asian-Pacific countries). In this article, we provide a new methodology for the design and analysis of bridging studies by assuming prior knowledge on how the null and alternative hypotheses in the original, foreign study are related to the null and alternative hypotheses in the bridging study and setting the type I error for the bridging study according to the strength of the foreign-study evidence. The new methodology accounts for randomness in the foreign-study evidence and controls the average type I error of the bridging study over all possibilities of the foreign-study evidence. In addition, the new methodology increases statistical power, when compared to approaches that do not use foreign-study evidence, and it allows for the possibility of not conducting the bridging study when the foreign-study evidence is unfavorable. Finally, we conducted extensive simulation studies to demonstrate the usefulness of the proposed methodology.

Designing dose finding studies with an active control for exponential families

Optimal design of dose-finding studies with an active control has only been considered in the literature for regression models with normally distributed errors and known variances, where the focus is on estimating the smallest dose that achieves the same treatment effect as the active control. This paper discusses such dose-finding studies from a broader perspective. We consider a general class of optimality criteria and models arising from an exponential family. Optimal designs are constructed for several situations and their efficiency is illustrated with examples.